Profile
Mark Mannebach is currently the Head of Regulatory Affairs & Pharmacovigilance at Harrow, Inc. and the Vice President of Regulatory Affairs at Celcuity, Inc. He previously held positions as the Vice President of Global Regulatory Affairs at Eiger BioPharmaceuticals, Inc., Exicure, Inc., Santen, Inc., and Mallinckrodt Pharmaceuticals.
Dr. Mannebach has a background in regulatory affairs and pharmacovigilance.
He obtained his undergraduate degree from Wayne State University, his graduate degree from the University of Detroit Mercy, and his doctorate from the University of Michigan.
Mark Mannebach active positions
Companies | Position | Start |
---|---|---|
HARROW, INC. | General Counsel | 06/03/2023 |
CELCUITY INC. | General Counsel | 01/04/2022 |
Former positions of Mark Mannebach
Companies | Position | End |
---|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | General Counsel | 01/11/2008 |
EXICURE, INC. | General Counsel | - |
EIGER BIOPHARMACEUTICALS, INC. | General Counsel | - |
Training of Mark Mannebach
University of Michigan | Doctorate Degree |
University of Detroit Mercy | Graduate Degree |
Wayne State University (Michigan) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
EXICURE, INC. | Health Technology |
HARROW, INC. | Health Technology |
CELCUITY INC. | Health Technology |
Private companies | 1 |
---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
- Stock Market
- Insiders
- Mark Mannebach